Build your foundation. Avoid costly mistakes. Get grounded in the essentials of export controls and compliance. This session covers the key regulations, common pitfalls (including dual-use items), and why compliance matters – because mistakes can carry serious consequences. Perfect for…
Post-Entry
Post-Entry
November 21, 2024/
You got it in, now what?
Your responsibilities aren't over just because you got your goods across the border. We talk about the next steps you need to take to make sure you're in compliance and ready for anything Customs might send your way.
Topics Include:
- Legal & regulatory obligations
- Risk management
- Post-entry challenges
Related Posts
NMFS: Upcoming Import Prohibitions and Industry Webinars
The National Marine Fisheries Service (NMFS) announces that, effective January 1, 2026, imports of specific fish and fish products from countries whose fisheries have not received comparability findings under the Marine Mammal Protection Act (MMPA) will be restricted from entering the United States. To help industry prepare for these changes, NMFS will host two informational…
CBP: Settlement Reached in Aluminum Extrusions Duty Evasion Case
Harman International Industries, parent company of Harman Kardon®, JBL®, and Mark Levinson®-has agreed to pay $11,809,628 to settle allegations that it evaded antidumping and countervailing duties (ADCVD) on aluminum-extrusion heatsinks imported from China. According to the allegations, the company failed for more than a decade to disclose or correct the violations and actively concealed the…
Year-End Insights Webinar 3: How to Prepare for 2026
Strategies, Tools & Talent for What’s Next! During the session Star USA’s president, Michael D. Easton, opened with key takeaways from our previous webinar. Licensed Customs Broker DeAndra Ballard then walked through the fundamentals of tariffs. The webinar concluded with a look ahead to trade and compliance in 2026 and a Q&A session with the…
USTR: U.S. and U.K. Reach Agreement on Pharmaceuticals and Medical Technology
On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations related to U.K. pharmaceutical pricing during President Trump’s term, and collaborate to expand U.K. patient…